Bioventus

BVS · NASDAQ

$13.95+$0.46 (+3.41%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $13.49

Latest news

NewsAug 7, 1:12 PM ETCaroline Ryan
Deal Dispatch: Bending Spoons Acquires Airtable, Bain Capital Buys Gong Cha Global, Salad and Go Bankruptcy
NewsAug 5, 7:34 AM ET
Bioventus Q2 Adj. EPS $0.22, Inline, Sales $153.208M Miss $155.640M Estimate
Press releaseAug 5, 7:30 AM ETGlobe Newswire
Bioventus Reports Second Quarter Financial Results
NewsAug 3, 12:42 AM ETTim Melvin
5 Growth Stocks That Pass Peter Lynch's Favorite Test
NewsJul 29, 3:30 PM ETTim Melvin
Under the Radar: 3 Boring Small Caps That Could Return 10x
Press releaseJul 3, 12:24 PM ETPRNewswire
Did Bioventus Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Press releaseJun 2, 9:00 AM ETPRNewswire
The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts
NewsJun 1, 6:46 AM ET
Transcript: Bioventus Q1 2026 Earnings Conference Call
Press releaseMay 22, 10:31 AM ETPRNewswire
Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
NewsMay 6, 7:31 AM ET
Bioventus Q1 Adj. EPS $0.15 Beats $0.10 Estimate, Sales $132.089M Beat $129.850M Estimate
Press releaseMay 6, 7:30 AM ETGlobe Newswire
Bioventus Reports First Quarter Financial Results
Press releaseMar 5, 7:00 AM ETGlobe Newswire
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results
NewsMar 4, 12:02 PM ET
Preview: Bioventus's Earnings
Press releaseDec 5, 3:30 PM ETPRNewswire
HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS
Press releaseNov 4, 7:30 AM ETGlobe Newswire
Bioventus Reports Third Quarter Financial Results
Press releaseOct 22, 7:08 PM ETBusiness Wire
Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights
Press releaseAug 6, 7:00 AM ETGlobe Newswire
Bioventus Reports Second Quarter Financial Results
Press releaseAug 4, 8:00 AM ETGlobe Newswire
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity
NewsMay 5, 2:02 PM ET
Examining the Future: Bioventus's Earnings Outlook
NewsNov 5, 2:32 PM ETAvi Kapoor
Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings
NewsNov 5, 1:36 PM ETAvi Kapoor
S&P 500 Gains 1%; Vimeo Shares Spike Higher
NewsNov 5, 11:34 AM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsNov 5, 9:48 AM ETAvi Kapoor
Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September
NewsAug 6, 11:47 AM ETAvi Kapoor
Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday
Press releaseAug 2, 9:00 PM ETGlobe Newswire
BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Deal Dispatch: Bending Spoons Acquires Airtable, Bain Capital Buys Gong Cha Global, Salad and Go Bankruptcy

Bioventus Q2 Adj. EPS $0.22, Inline, Sales $153.208M Miss $155.640M Estimate

Bioventus Reports Second Quarter Financial Results

5 Growth Stocks That Pass Peter Lynch's Favorite Test

Under the Radar: 3 Boring Small Caps That Could Return 10x

Did Bioventus Inc. Insiders Breach their Fiduciary Duties to Shareholders?

The Body as Blueprint: A Recently Public Biotech Bets That Regrown Tissue Beats Replacement Parts

Transcript: Bioventus Q1 2026 Earnings Conference Call

Regenerative Medicine's Newest Public Company Is Building Tissue, Not Replacing It

Earnings Scheduled For May 6, 2026

Bioventus Q1 Adj. EPS $0.15 Beats $0.10 Estimate, Sales $132.089M Beat $129.850M Estimate

Bioventus Reports First Quarter Financial Results

Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results

Preview: Bioventus's Earnings

HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Bioventus Reports Third Quarter Financial Results

Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights

Bioventus Reports Second Quarter Financial Results

Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity

Examining the Future: Bioventus's Earnings Outlook

Dow Jumps 400 Points; Yum! Brands Posts Downbeat Earnings

S&P 500 Gains 1%; Vimeo Shares Spike Higher

12 Health Care Stocks Moving In Tuesday's Intraday Session

Nasdaq Gains Over 100 Points; US Trade Deficit Widens In September

Yum China Posts Upbeat Earnings, Joins Clear Secure, TG Therapeutics, Bioventus And Other Big Stocks Moving Higher On Tuesday

BIOVENTUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Bioventus Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm